NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

When it comes to enviable hair, you'd be hard-pushed to find someone with more universally appealing locks than Princess Kate. Whether she's posing for portraits, attending exclusive soirees or ...

Cell cultures after 72 h incubation with (a) uninfected cells, and (b–d) aerosol samples (collected during singing) from SARS-CoV-2 infected individuals. Cytopathic effect is partly demonstrated ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.